Millennium Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.89M | Buy |
+642,448
| New | +$2.81M | ﹤0.01% | 3506 |
|
|
2025
Q4 | – | Sell |
-528,340
| Closed | -$2.4M | – | 5950 |
|
|
2025
Q3 | $2.4M | Buy |
528,340
+28,857
| +6% | +$106K | ﹤0.01% | 3870 |
|
|
2025
Q2 | $1.54M | Buy |
499,483
+151,263
| +43% | +$502K | ﹤0.01% | 4097 |
|
|
2025
Q1 | $1.22M | Buy |
348,220
+5,192
| +2% | +$17.3K | ﹤0.01% | 4210 |
|
|
2024
Q4 | $1.12M | Buy |
343,028
+92,068
| +37% | +$339K | ﹤0.01% | 4108 |
|
|
2024
Q3 | $966K | Buy |
250,960
+41,991
| +20% | +$161K | ﹤0.01% | 4309 |
|
|
2024
Q2 | $646K | Sell |
208,969
-33,243
| -14% | -$99.7K | ﹤0.01% | 4430 |
|
|
2024
Q1 | $625K | Sell |
242,212
-1,295,712
| -84% | -$3.36M | ﹤0.01% | 4661 |
|
|
2023
Q4 | $3.84M | Sell |
1,537,924
-45,648
| -3% | -$89.4K | ﹤0.01% | 3015 |
|
|
2023
Q3 | $3.21M | Sell |
1,583,572
-118,610
| -7% | -$249K | ﹤0.01% | 3134 |
|
|
2023
Q2 | $3.92M | Buy |
1,702,182
+41,616
| +3% | +$108K | ﹤0.01% | 2887 |
|
|
2023
Q1 | $5.03M | Sell |
1,660,566
-192,149
| -10% | -$542K | ﹤0.01% | 2600 |
|
|
2022
Q4 | $4.32M | Sell |
1,852,715
-1,657,473
| -47% | -$3.97M | ﹤0.01% | 2939 |
|
|
2022
Q3 | $6.7M | Sell |
3,510,188
-648,876
| -16% | -$1.53M | ﹤0.01% | 2608 |
|
|
2022
Q2 | $11.3M | Buy |
4,159,064
+2,142,740
| +106% | +$5.48M | 0.01% | 1907 |
|
|
2022
Q1 | $6.01M | Sell |
2,016,324
-1,022,861
| -34% | -$3.13M | ﹤0.01% | 2727 |
|
|
2021
Q4 | $11.8M | Buy |
3,039,185
+2,017,490
| +197% | +$7.84M | 0.01% | 1968 |
|
|
2021
Q3 | $4.38M | Buy |
+1,021,695
| New | +$3.4M | ﹤0.01% | 3013 |
|
|
2021
Q2 | – | Sell |
-523,263
| Closed | -$1.74M | – | 6453 |
|
|
2021
Q1 | $1.74M | Buy |
523,263
+342,301
| +189% | +$1.32M | ﹤0.01% | 3660 |
|
|
2020
Q4 | $642K | Buy |
+180,962
| New | +$634K | ﹤0.01% | 4019 |
|
|
2020
Q3 | – | Sell |
-222,573
| Closed | -$405K | – | 4384 |
|
|
2020
Q2 | $405K | Sell |
222,573
-624,591
| -74% | -$1.02M | ﹤0.01% | 3529 |
|
|
2020
Q1 | $856K | Buy |
847,164
+551,188
| +186% | +$1.49M | ﹤0.01% | 2563 |
|
|
2019
Q4 | $823K | Sell |
295,976
-60,090
| -17% | -$97.2K | ﹤0.01% | 3091 |
|
|
2019
Q3 | $543K | Sell |
356,066
-164,959
| -32% | -$284K | ﹤0.01% | 3203 |
|
|
2019
Q2 | $1.08M | Buy |
+521,025
| New | +$1.33M | ﹤0.01% | 2757 |
|
|
2018
Q4 | – | Sell |
-30,924
| Closed | -$292K | – | 3696 |
|
|
2018
Q3 | $292K | Sell |
30,924
-56,165
| -64% | -$558K | ﹤0.01% | 3493 |
|
|
2018
Q2 | $636K | Buy |
87,089
+73,882
| +559% | +$440K | ﹤0.01% | 3056 |
|
|
2018
Q1 | $66K | Sell |
13,207
-68,800
| -84% | -$364K | ﹤0.01% | 3518 |
|
|
2017
Q4 | $414K | Buy |
82,007
+61,961
| +309% | +$363K | ﹤0.01% | 3187 |
|
|
2017
Q3 | $124K | Buy |
+20,046
| New | +$85.7K | ﹤0.01% | 3336 |
|
|
2017
Q2 | – | Sell |
-45,818
| Closed | -$149K | – | 3404 |
|
|
2017
Q1 | $149K | Buy |
45,818
+26,614
| +139% | +$73.8K | ﹤0.01% | 3279 |
|
|
2016
Q4 | $47K | Sell |
19,204
-456,918
| -96% | -$1.33M | ﹤0.01% | 3257 |
|
|
2016
Q3 | $1.64M | Sell |
476,122
-109,954
| -19% | -$430K | ﹤0.01% | 2036 |
|
|
2016
Q2 | $2.04M | Sell |
586,076
-211,664
| -27% | -$896K | ﹤0.01% | 1770 |
|
|
2016
Q1 | $3.29M | Sell |
797,740
-406,705
| -34% | -$1.45M | 0.01% | 1499 |
|
|
2015
Q4 | $5.36M | Sell |
1,204,445
-151,394
| -11% | -$830K | 0.01% | 1313 |
|
|
2015
Q3 | $8.26M | Sell |
1,355,839
-7,186
| -0.5% | -$63.7K | 0.02% | 1040 |
|
|
2015
Q2 | $16.2M | Buy |
1,363,025
+988,268
| +264% | +$15M | 0.03% | 725 |
|
|
2015
Q1 | $6.54M | Buy |
+374,757
| New | +$7.68M | 0.01% | 1271 |
|
|
2014
Q4 | – | Sell |
-12,600
| Closed | -$266K | – | 3866 |
|
|
2014
Q3 | $266K | Sell |
12,600
-130,226
| -91% | -$2.13M | ﹤0.01% | 3180 |
|
|
2014
Q2 | $1.86M | Buy |
142,826
+123,267
| +630% | +$1.75M | 0.01% | 1826 |
|
|
2014
Q1 | $420K | Buy |
+19,559
| New | +$351K | ﹤0.01% | 2726 |
|
Other funds holding ABUS
TSC
WCM
VCM
RCMNY
ACM
Millennium Management's ABUS Position: Q1 2026 in Review
Millennium Management opened a new position in Arbutus Biopharma (ABUS) in Q1 2026: 642,448 shares worth $2.89M. The stake represents ﹤0.01% of the portfolio and ranks #3506 among its holdings. This is a return to the name: Millennium Management previously reported a position in ABUS as recently as Q3 2025.
Millennium Management first reported a position in ABUS in Q1 2014 and has held it in 42 quarters since. The position peaked at $16.2M in Q2 2015. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.
- Millennium Management held 642,448 shares of Arbutus Biopharma worth $2.89M as of Q1 2026.
- Arbutus Biopharma was a new Millennium Management position in Q1 2026.
- Arbutus Biopharma made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3506 holding.
- Millennium Management first reported a position in Arbutus Biopharma in Q1 2014 and has held it in 42 quarters since.
- Millennium Management's Arbutus Biopharma position peaked at $16.2M in Q2 2015.
- 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.